Nasal IVIG study for long COVID patients with immune problems
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a nasal spray form of IVIG (an immune-boosting treatment) can help people with Long COVID who also have certain immune system issues. It aims to see if the treatment is safe and effective for this group of patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have had Long COVID symptoms for at least 12 weeks after a COVID infection
- You have a confirmed immune deficiency (like low antibody levels or high inflammation markers)
- You do not have any active infections right now
- You are not taking medications that suppress your immune system
- You are willing to share your health data for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.
This trial tests a treatment made from donated umbilical cord blood, called REGENECYTE, to see if it helps people with long COVID feel better. It is for adults who still have symptoms after COVID-19 and have tested negative for the virus recently.
This study tests whether medicines that fight viruses (similar to those used for herpes or COVID) can reduce Long COVID symptoms like fatigue and brain fog. Researchers believe lingering viruses or viral reactivation may drive Long COVID, and this trial will see if antiviral drugs help.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.
This trial tests if filtering certain antibodies from the blood can help people with long COVID who experience post-exertional malaise (PEM) and reduced function. It aims to see if this treatment reduces symptoms and improves daily life.
Hear when a new Post Acute Sequelae of SARS CoV 2 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.